INTRODUCTION
Glutamate is the principal excitatory neurotransmitter in the brain. In the central nervous system, both neurons and astrocytes are known to release glutamate; the neuronal glutamate mediates fast synaptic transmission (Traynelis et al., 2010) , whereas the astrocytic glutamate appears to modulate synaptic transmission (Haydon and Carmignoto, 2006) . Although it is clear that neurons release glutamate via Ca 2+ -dependent exocytosis, the mechanism of astrocytic glutamate release has been heavily debated, and many controversial issues have been raised (Hamilton and Attwell, 2010; Nedergaard et al., 2002) . The field seems to be divided into three conflicting views: (1) astrocytes release glutamate by vesicular exocytosis, just like neurons (Bezzi et al., 2004; Jourdain et al., 2007) ; (2) Ca 2+ -dependent astrocytic glutamate does not do anything important (Agulhon et al., 2010) ; or (3) glutamate is released from astrocytes by transporters or channels (Cavelier and Attwell, 2005; Hamilton and Attwell, 2010; Li et al., 2012; Takano et al., 2005; Ye et al., 2003) . Such controversies most likely stem from the inconsistencies in procedures used to increase intracellular Ca 2+ , such as UV photostimulation (Parpura et al., 1994) , mechanical stimulation (Araque et al., 1998 (Araque et al., , 2000 Montana et al., 2004) , electrical stimulation (Jourdain et al., 2007; Kang et al., 1998) , uncaging of caged Ca 2+ or IP 3 (Araque et al., 1998; Fiacco and McCarthy, 2004; Parpura and Haydon, 2000) , and G-protein-coupled receptor (GPCR) agonists (Lee et al., 2007; Takano et al., 2005) . More importantly, there is no sensitive method to detect glutamate release from individual astrocytes. Conventional techniques include fluorescence imaging of glutamate dehydrogenase activity through NAD + to NADH conversion (Innocenti et al., 2000) , detection of preloaded radioactive glutamate release (Farinelli and Nicklas, 1992) , and high-performance liquid chromatography (HPLC) (Obrenovitch and Zilkha, 2001; Takano et al., 2005) . However, these methods lack the desired submillisecond temporal resolution. In contrast, it has been relatively easy to understand the exocytosis-mediated release of glutamate from presynaptic vesicles because of the availability of high-sensitivity sensors for synaptic glutamate release, namely the postsynaptic AMPA and NMDA receptors (Clements et al., 1992) .
In our previous study, we developed the ''sniffer-patch'' technique, a highly sensitive method for detecting astrocytic glutamate release that is based on a biosensor consisting of HEK293T cells that transiently express a nondesensitizing mutant form of the AMPA receptor subunit, GluR1-L497Y (Lee et al., 2007) . This receptor has a high affinity for glutamate (median effective concentration [EC 50 ] = 6.1 mM), allowing detection of submicromolar glutamate levels, a fast activation rate (submillisecond) for detection of rapid release, and a fast deactivation rate (0.7-1.2 ms) for better kinetic separation of different components of glutamate release (Traynelis et al., 2010) . To stimulate individual astrocytes with more physiological stimuli, we activated endogenous GPCRs by pressure-applied TFLLR (Hollenberg et al., 1997) , a selective peptide agonist of the protease-activated receptor 1 (PAR1). PAR1 is a GPCR that is activated via serine proteases such as thrombin and plasmin by proteolytic cleavage of the N terminus of the receptor, revealing a tethered ligand with a peptide sequence of SFLLRN, which acts as an agonist (Macfarlane et al., 2001) . TFLLR mimics the tethered ligand and has been shown to be more selective to PAR1 over PAR2 than the native peptide sequence, SFLLRN (Hollenberg et al., 1997) . PAR1 is functionally expressed in most of CA1 hippocampal astrocytes, but not in CA1 pyramidal neurons (Junge et al., 2004) , and is linked to G i/o , G q/11 , and G 12 proteins (Sorensen et al., 2003) .
In the present study, we utilized the sniffer patch to dissect the detailed mechanism of GPCR-induced glutamate release in astrocytes. We found that astrocytes release glutamate not by conventional vesicular exocytosis but by the opening of glutamate-permeable ion channels. Furthermore, we found that the drugs or agents that are assumed to inhibit exocytosis and are used to support the vesicular theory of astrocytic glutamate release strongly reduced the surface expression of multiple ion channels, including those that mediate glutamate release.
RESULTS

Characterization of Fast and Slow Modes of Glutamate Release
The general scheme of sniffer patch is illustrated in Figure 1A . On the day of experiment, sensor cells were mixed with astrocytes and allowed to randomly settle on top of individual astrocytes (Figure S1A available online). The sensor cell was then whole-cell patch clamped to monitor released glutamate from its nearby astrocyte. TFLLR was applied while simultaneously monitoring Fura-2 intensity ratio for astrocytic Ca 2+ signal ( Figures 1B  and 1C ) (Lee et al., 2007) .
Upon TFLLR application, glutamate release was detected as an inward current in the sensor cell mediated by GluR1-L497Y. Glutamate release consisted of both fast (latency: 120.0 ± 13.3 ms, n = 33) and slow (time at the peak: 20.2 ± 2.5 s, n = 33) modes ( Figure 1C ). TFLLR application never induced a current in the sensor cell in the absence of an astrocyte ( Figures  S1C and S1G ). In the presence of astrocyte buffer without TFLLR or RLLFT, a reverse peptide of TFLLR never caused a sensor current ( Figures S1D and S1E ). However, SFLLR caused a robust sensor current ( Figure S1F ), just like TFLLR. Bath application of 1 mM glutamate was used to fully activate the GluR1-L497Y channels expressed in the sensor cell ( Figure 1D ) and to thereby estimate the percent of full activation of GluR1-L497Y activated by astrocytic glutamate release. This percentage can be easily converted to the concentration of glutamate, based on the concentration-response relationship of GluR1-L497Y (Lee et al., 2007) . Each response could be categorized into three groups: fast only, slow only, and both modes (Figures S1H-S1J). Most of astrocytes fell into the ''both'' category (69.3%), though the existence of fast-only (18.1%) and slow-only (12.6%) responses raised the possibility that each component is mediated by a distinct mechanism. The average fraction of receptor activation at the peak of response was greater for the fast mode than for the slow ( Figure S1K ). However, the total charge was much greater for the slow mode than for the fast ( Figure S1L ). These two modes and the full-activation current were almost completely blocked by the AMPA receptor blocker CNQX (Figures S1H-S1J, right panels, S1M, and S1B), indicating that glutamate is responsible for both the fast and slow modes. The TFLLR-induced glutamate release was readily repeatable with 10 min intervals ( Figure S1N ). The fast mode preceded the onset of TFLLR-induced Ca 2+ increase (Figures 1C and S1O-S1Q), implying the involvement of a Ca 2+ -independent release mechanism. In contrast, the slow mode occurred in association with the rise of astrocytic Ca 2+ ( Figure S1R ), implying a Ca 2+ -dependent mechanism. The response to the fast mode of astrocytic glutamate release was as fast as the response to exocytosis-mediated neuronal release, suggesting a very rapid mechanism (Figures S1S-S1X).
To examine the signaling pathways mediating the fast and slow modes of glutamate release, we utilized various molecular and pharmacological tools. Because the PAR1 receptor is linked (G) Summary bar graph for percentage of full activation in each indicated condition (**1, p = 0.005; **2, p = 0.001; unpaired t test). Number on each bar indicates n for each condition. to both G i/o and G q/12 , we selectively inhibited the G i pathway by preincubating astrocytes with pertussis toxin (PTX), which is known to inhibit the action of G i subunit by ADP-ribosylation (West et al., 1985) . We found that PTX selectively and almost completely blocked the fast, but not the slow, mode of glutamate release ( Figures 1E and 1G ) without affecting astrocytic Ca 2+ responses ( Figures S2A and S2B ). This selective inhibition by PTX was significantly rescued by overexpression of a PTX-insensitive form of G i (Figures 1F and 1G) (Digby et al., 2008) , but not by overexpression of the G s subunit ( Figure 1G ). Activation of GPCRs is known to dissociate the G bg complex from the trimeric G i -G bg complex (Koch et al., 1993) . Thus, we further tested the role of G i by asking whether disturbing the G bg dissociation affects the fast mode. Overexpression of the C terminus of phosducin or b-ARK, which has been reported to inhibit G bg dissociation (Blü ml et al., 1997; Koch et al., 1993) , almost completely inhibited the fast mode ( Figures 1H and 1I ) without affecting the Ca 2+ responses ( Figures S2C and S2D ). Furthermore, well-known agonists of G i -coupled GPCR could induce fast glutamate release; baclofen, GABA B agonist, 2-chloro-N(6)-cyclopentyladenosine (CCPA), adenosine receptor A1 agonist, arachidonyl-2 0 -chloroethylamide (ACEA), and cannabinoid receptor CB1 agonist all activated a fast mode of glutamate release, which was similar to that induced by TFLLR, without a measurable Ca 2+ increase or a slow mode of glutamate release ( Figures 1J, 1K , S2G, and S2H).
To examine the involvement of G q signaling, we overexpressed RGS-2, which is reported to selectively inhibit the G q subunit (Heximer et al., 1997) . We found that RGS-2 overexpression selectively and significantly inhibited both the slow mode of glutamate release and the associated Ca 2+ increase while not affecting the fast mode ( Figures 1L, 1M , S2E, and S2F). G q signaling activates phospholipase Cb, producing IP 3 and releasing Ca 2+ through the IP 3 R channel (Clapham, 2007 ). Thus, we tested the sensitivity of slow mode to the Ca 2+ chelator, BAPTA. We found that 30 min treatment with BAPTA-AM eliminated the TFLLR-induced Ca 2+ response and significantly reduced the slow mode, but not the fast mode ( Figures 1N and 1O ). These results indicate that the slow mode is preferentially linked to G q signaling and subsequent Ca 2+ release. To test the involvement of G s , which produces cyclic AMP (cAMP), we applied TFLLR in the presence of IBMX, an inhibitor of cAMP phosphodiesterase, or forskolin, an activator of adenylyl cyclase, and found no evidence for the involvement of cAMP in the fast or slow components of glutamate release ( Figures S2I-S2K ).
Vesicular Exocytosis Is Not Involved
Next, we examined whether vesicular exocytosis is involved in the fast and slow modes of glutamate release. First, we applied hyperosmotic solution, which causes exocytotic release of glutamate in neurons (Bekkers and Stevens, 1995) , and found that this evoked no glutamate release from astrocytes (Figures S3A and S3C; Lee et al., 2007) . Unlike neurons, astrocytes apparently do not possess glutamate-containing vesicles sensitive to hyperosmotic solution. Rose Bengal, which inhibited glutamate released by mechanical stimulation (Montana et al., 2004) , did not have any effect on the fast or slow modes of glutamate released by TFLLR ( Figures S3B and S3C ). Treatment of astrocytes with Bafilomycin A1 and Concanamycin A, which should deplete glutamate from synaptic vesicles, appeared to block both fast and slow modes, presumably due to the fact that these compounds almost completely eliminated the surface expression of GluR1-L497Y in the sensor cell ( Figures S3D-S3G , S3I, and S3K). Tetanus toxin (TeTX) also caused the similar effect of removing surface GluR1-L497Y ( Figures S3J and S3K ), complicating the interpretation of any results obtained using this toxin. To avoid the effects of drugs and toxins on the sensor cell, we injected Botulinum toxin B (BoToxB), together with Ca 2+ indicator dye Fura-2, into individual astrocytes through the patch pipette. This did not cause any significant effect on the surface expression of GluR1-L497Y on the sensor cell ( Figures S3M and S3P ). We found that BoToxB injection did not have any effect on TFLLRinduced fast and slow modes ( 2D ). From these results, we conclude that, whereas the glutamate released by mechanical stimulation is sensitive to inhibitors of exocytosis, glutamate released by TFLLR is not.
Molecular Identities of Fast and Slow Modes of Glutamate Release
We next examined the possibility that TFLLR induces glutamate release from astrocytes via channels or transporters. We screened blockers of various channels and glutamate transporters and found that both the fast and slow modes of release were blocked by blockers of Ca 2+ -activated anion channel (CAAC), such as NPPB, niflumic acid, DIDS ( Figures 2E, S4A , and S4B), and quinine, which blocks two-pore potassium (K2P) channels (Figures 2F and S4C) . Although these blockers are notorious for their nonspecific effects (Greenwood and Leblanc, 2007; Wang et al., 1997) , they did not have any effect on the sensor, GluR1-L497Y ( Figures S4D and S4E ). Blockers that did not show any significant effect include TTX (voltage-gated sodium channels), Cd 2+ (voltage-gated Ca 2+ channels), TEA, Ba 2+ , Cs + (potassium channel), CBX (gap junction hemichannel),
and DCPIB (volume-sensitive anion channel) ( Figure S4G ). PPADS (P2X channel) appeared to block the fast mode (Figure S4G) , but this was not interpretable because PPADS had nonspecific effects . From the results of this screening, CAAC and K2P channels emerged as strong candidates as molecular mediators of receptor-mediated glutamate release from astrocytes.
To determine the molecular identity of the slow mode, we first tested the Bestrophin-1(Best1) channel because this Ca 2+ -activated anion channel is highly expressed in hippocampal astrocytes (Park et al., 2009) . It also shows unique properties such as permeability to glutamate (Park et al., 2009 ) and GABA ( Lee et al., 2010) . Although Best1 channel is permeable to both glutamate and GABA, it is not likely to mediate GABA release from hippocampal astrocytes because hippocampal astrocytes do not contain GABA (Yoon et al., 2011) , unlike the cerebellar Bergmann glial cells . Silencing the Best1 gene via specific small hairpin RNA (shRNA) for mouse Best1 selectively reduced the slow mode without significantly affecting the fast mode ( Figures 2G, 2H , and 2K). This effect was specific because it was not observed with a control scrambled shRNA and was fully rescued by the cotransfection of Best1-shRNA, along with an shRNA-insensitive form of Best1 ( Figure 2K ). However, the addition of a pore mutation at position 93, from tryptophan to cysteine (Best1-W93C) (Zhang et al., 2010) , failed to rescue the slow mode, indicating that permeation of glutamate through the pore of Best1channel is responsible for the slow mode ( Figure 2K ).
For the fast mode, we next explored the possibility of TREK-1, which is a recently proposed K2P channel in astrocytes (Zhou et al., 2009 ). An shRNA specific for mouse TREK-1 was developed (Figures S4K-M) and tested for effects on glutamate release. Gene silencing of TREK-1 selectively eliminated the fast mode without affecting the slow mode ( Figures 2I and 2L ) and was fully rescued by rat TREK-1, which is insensitive to mouse TREK-1-shRNA ( Figure 2L ). However, the addition of a pore mutation at position 144, from glycine to glutamate (rTREK-1-G144E) (Brenner and O'Shaughnessy, 2008) , failed to rescue the fast mode. Finally, cotransfecting the shRNAs for Best1 and TREK-1 eliminated both the fast and slow modes ( Figures  2J and 2L ).
Opening of Glutamate-Permeable Channel by Direct Binding of G bg to TREK-1 How can TREK-1, a potassium channel, conduct and release glutamate? TREK-1-mediated glutamate release is relatively fast and requires G i -G bg dissociation. To answer the question, we considered a possibility that G bg directly binds to TREK-1 to open a glutamate-permeable channel. A previous yeast twohybrid screen suggested that N terminus of TREK-1 interacts with GNG4 (subtype 4 of G g subunit) (Kim et al., 2010) . Therefore, we performed a detailed analysis of N-terminal region of TREK-1 by yeast two-hybrid assay ( Figures 3A and S5A ). Of the four segments of N-terminal region of TREK-1, each with 11 or 12 amino acid residues, we found that the N1, N2, and N4 segments strongly interacted with GNG4, whereas N3 did not ( Figures 3A,  3B , and S5B). The interaction of TREK-1 N terminus with GNG4 was also confirmed by MBP pull-down assay ( Figure S5C ). We confirmed the interaction between full-length TREK-1 and GNG4 via coimmunoprecipitation by using the antibodies against hemagglutinin (HA) and green fluorescent protein (GFP) after heterologously expressing GFP-GNG4 and HA-TREK-1 in HEK293T cells ( Figure 3C ). As a positive and negative control, we performed similar experiments with a well-known G bg -interacting channel, GIRK (G-protein-coupled inwardly rectifying potassium channel), and a noninteracting IRK (inwardly rectifying potassium channel). We found that GIRK strongly interacted with GNG4, whereas IRK did not ( Figure 3C ), as expected (Huang et al., 1995) . Furthermore, RT-PCR analysis showed that cultured astrocytes express GNG4 ( Figure S5G ).
To map out the region of GNG4 that interacts with TREK-1, we divided the GNG4 protein sequence (75 amino acids) into two segments, N (1-31)-and C (32-75)-terminal segments, and checked for protein-protein interaction with full-length TREK-1 by coimmunoprecipitation ( Figure 3D ). The results showed that C terminus of GNG4 showed strong interaction with TREK-1, whereas N terminus did not ( Figure 3D ). To test the specificity of different GNG isoforms, we first cloned 11 out of 12 known isoforms of GNG family from the complementary DNAs (cDNAs) of primary cultured mouse astrocytes. The analysis of sequence homology between isoforms indicated that there are wellconserved N-helix and C-helix ( Figure S5H ), and the phylogenic tree indicated a close homology between GNG1 and GNG11 and between GNG5 and GNG10 ( Figure S5I and Table S1 ). Then we performed a coimmunoprecipitation experiment for each GNG isoform against TREK-1 and found that most GNG isoforms coimmunoprecipitated with TREK-1 protein. In contrast, GNG5 and GNG10 showed a lack of interaction, and GNG1 and GNG11 showed a weak interaction ( Figure S5J ), indicating that GNG binding to TREK1 is isoform specific.
We then asked whether G bg can directly open any channels in cultured astrocytes. We performed whole-cell current recording with purified G bg in the patch pipette and found that a large inward current was induced by intracellularly applied G bg upon the membrane rupture (V h = À70mV). Surprisingly, the reversal potential of this current (À3.8 ± 0.2mV, n = 19) was far away from the equilibrium potential for K + (À70mV) or Na + (40mV) but was near the Cl À equilibrium potential (0mV; Figures S5D-S5F ). Ion substitution experiments showed that the G bg -induced current was mostly carried by Cl À ion because of the linear current-voltage (I-V) relationship and reversal potential near 0mV, which was observed when identical Cl À concentrations were present on both sides of the plasma membrane ( Figure 3E , black trace). As a control, we used BSA, which did not induce any significant current ( Figure 3E , blue trace). To determine whether the conductance shows permeability to glutamate, we substituted Cl À in the intracellular pipette solution with glutamate and found that G bg induced a significant inward current at À100mV with reversal potential around À40mV ( Figure 3E , red trace), indicating a significant glutamate permeability. From the average shift in reversal potential of À30.9mV produced by the substitution of intracellular Cl À with glutamate (Figure 3G) , we calculated the permeability ratio of glutamate to Cl À (P glutamate /P Cl À ) to be 0.27 by using the Goldman-HodgkinKatz equation. In the absence of G bg , the conductance for glutamate, as well as that for Cl À , was negligible ( Figure 3F ). From the concentration-response relationship, EC 50 for G bg was determined to be 32.4 ng/ml (0.79 nM) ( Figure 3J ).
To test whether the G bg -induced glutamate conductance is mediated by TREK-1, we performed a similar experiment after silencing the TREK-1 gene with shRNA. Compared to the scrambled shRNA ( Figure 3H black trace and 3I), we found that mouse TREK-1-shRNA eliminated the G bg -induced conductance (blue trace), which was significantly rescued by coexpression of rat TREK-1 (red trace). The pore mutant rTREK-1-G144E failed to rescue the G bg -induced conductance (green trace). These results indicate that TREK-1 mediates the glutamate conductance induced by G bg . Because N1, N2, and N4 of TREK-1 interact with GNG4, we tested for functional interaction by using these competitive peptides. Inclusion of competitive peptides N1, N2, and N4 in the patch pipette significantly reduced G bginduced chloride currents ( Figures 3K-3N) .
To determine whether activation of TREK-1 by G bg can release glutamate from astrocytes, we performed two-cell sniffer patch . Under this configuration, two patch pipettes were used: one containing both G bg and 5 mM glutamate to record from an astrocyte and the other for a sensor cell expressing GluR1-L497Y to detect released glutamate. Upon membrane rupture, the astrocyte showed a large inward current (Vh = À70mV), and the sensor cell displayed a substantial parallel current representing glutamate released from the neighboring astrocyte ( Figures 4A and 4B) . Outflow of glutamate from astrocyte was dependent on the electrochemical gradient because changing the holding potential from À70mV to +70mV reduced glutamate release by $75% (Figures 4A-4C) , as predicted by the Nernst equation. This glutamate release was eliminated by silencing the TREK-1 gene in astrocytes and was rescued by coexpression of rat TREK-1 (Figures 4D-4F) . The pore mutant rTREK-1-G144E failed to rescue ( Figure 4F ). These results indicate that astrocytic glutamate release can be directly induced by G bg and that TREK-1 mediates this release by direct permeation of glutamate through its pore. Finally, we tested whether TREK-1-mediated glutamate release requires direct binding of G bg to TREK-1 by utilizing the N-terminal segments of TREK-1 to compete for binding of G bg to TREK-1. We performed two-cell sniffer patch and found that N1 peptide significantly reduced the G bg -induced glutamate release, as well as G bg -induced current ( Figures 4H and 4I) , whereas N3 had no significant effect compared to the control condition without any peptide (Figures 4G and 4I ).
Best1 Is a Glutamate-Permeable Channel
We recently demonstrated that Best1 channel is activated by intracellular Ca 2+ (EC 50 = 150 nM) with considerable permeability to GABA Park et al., 2009 ) and that hippocampal astrocytes express CAAC with glutamate permeability Park et al., 2009 Figure 5A (black trace). We found a significant Ca 2+ -induced conductance carried by the efflux of Cl À or glutamate at À70mV, which was eliminated by the absence of free Ca 2+ in the pipette solution ( Figures 5A and 5B). The estimated permeability ratio of glutamate and Cl À was P glutamate /P Cl = 0.67 (E rev of internal Cl À : 1.9 ± 0.8mV, n = 9; E rev of internal glutamate: À6.4 ± 2.0mV, n = 11; p = 0.0019) according to the Goldman-Hodgkin-Kats equation. These results indicate that Best1 channels show substantial permeability to glutamate, which is consistent with the previous reports O'Driscoll et al., 2009; Park et al., 2009) .
To determine whether such glutamate efflux through Best1 channel can be detected by a neighboring cell, we performed the two-cell sniffer patch between source cell and sensor cell ( Figure 5C ; Lee et al., 2010 ; Figure 5C ). We found that Best1 displayed a significant glutamate conductance ( Figure 5E , top blue trace) and that this current was associated with a sensor current ( Figure 5E , bottom green trace). We found that the release of glutamate depended on permeation through Ca 2+ -activated Best1 ( Figure 5D ) because it was absent (1) when Best1 was not expressed, (2) when glutamate was replaced by Cl À , (3) when Ca 2+ was absent ( Figure 5F ), and (4) when the source cell expressed the pore mutant of Best1 (W93C).
Differential Localization and Neuronal Targets of TREK-1 and Best1
To see whether the same kind of glutamate release is observed ex vivo, we performed sniffer-patch experiment and recorded CNQX-sensitive glutamate release from a single, acutely isolated, GFP-positive hippocampal astrocyte, which was prepared from the brain slices of adult GFAP-GFP transgenic mice (Figure 6A) . We similarly observed fast and slow modes of glutamate release ( Figures 6B and 6C ) with similar kinetic properties (fast mode latency: 61.5 ± 5.4 ms, n = 15; slow mode peak: 22.5 ± 4.3 s, n = 16). To test whether the same molecules are involved (F) Summary bar graph for sensor current (green) (**p = 0.008; *1, p = 0.041; *2, p = 0.038). in vivo, we first generated a lentivirus carrying TREK-1 shRNA and injected into wild-type hippocampal CA1 to perform sniffer-patch experiment from acutely isolated astrocytes. We found that TREK-1 shRNA selectively eliminated fast mode, as compared to the scrambled shRNA ( Figures 6D and 6G ). Then we tested Best1 knockout mice (Figures S7A and S7B; Marmorstein et al., 2006) and found that slow mode was selectively eliminated, as compared to the astrocytes of wild-type mice ( Figures 6E and 6G) . Finally, TREK-1 shRNA in Best1 knockout mice eliminated both fast and slow modes ( Figures 6F and 6G) .
Astrocytes show elaborate structures in vivo with several key cellular compartments. Of these structures, microdomains (E and F) Traces for two-cell sniffer patch from Best1-expressing source cell (Best1, blue) and sensor cell (green). Best1-expressing cells were patched and ruptured by using 145 mM glutamate-containing pipette solution with high 4.5 mM Ca 2+ (E) or 0 mM Ca 2+ (F) . Arrowheads, time point of membrane rupture of source cell.
All average values are expressed as mean ±SEM.
tightly wrap around each synapse (Grosche et al., 1999; Halassa et al., 2007) . To determine the subcellular distribution of the Best1 and TREK-1 channels and thus to predict the in vivo function, we performed electron microscopic immunohistochemistry with antisera against Best1 or TREK-1 and against GFP in GFAP-GFP mice. We found that Best1 channels were preferentially expressed at the surface membrane of microdomains adjacent to glutamatergic synapses ( Figure 6H ), as compared to other cellular compartments such as cell body and large processes ( Figures 6J and S6A-S6C ). The labeling in the large processes was located inside the processes rather than near or at the plasma membrane ( Figure S6B ), suggesting that these proteins are being transported out to the distal microdomains. In contrast to Best1, TREK-1 antibody showed opposite distribution pattern-namely, at the surface of cell body and processes, but not at the microdomains ( Figures 6I, 6J, and S6D-S6F) .
Next, the total amount of glutamate release from a single astrocyte was estimated based on the experimental values of sniffer-patch recording by using a diffusion model to fit the experimental measurements. The model was optimized to consider the geometrical constraints of sniffer patch and to capture the diffused-away glutamate molecules that the sensor failed to detect ( Figure 7A , see Extended Experimental Procedures). We calculated that one typical astrocyte releases 0.34 fmol of glutamate during the fast mode and 1.35 fmol during the slow mode ( Figures 7B and 7C) . These values could be compared to 2.64 fmol for the mechanical stimulation-induced glutamate release at the peak of response (Figures 7B and 7D) . These estimations are comparable to the previously reported estimations (0.078-0.2 fmol by glutamate imaging [Domercq et al., 2006] and 3 fmol by HPLC [Takano et al., 2005] ).
Using the same diffusion model, we simulated glutamate release from the point sources uniformly distributed on the astrocytic membrane and predicted the concentration of glutamate from 10 to 40 nm away from the neuronal membrane to mimic the astrocyte-neuron interaction ( Figures 7H and 7I ). Because the cytosolic glutamate concentration in astrocytes is as high as 2-10 mM (Ye et al., 2003) , glutamate is assumed to flow out, down the gradient when TREK-1 and Best1 channels open. The simulated glutamate concentration for the fast mode release via TREK-1 was $100 mM ( Figure 7E ) at the target receptor of the apposing neuronal membrane, whereas for slow mode via Best1, the concentration was $0.9 mM ( Figure 7F ). From these values, we can predict that the slow mode will preferentially activate neuronal NMDA receptors (NMDAR), whereas the fast mode will preferentially activate mGluR in addition to NMDAR, according to the reported concentration-response relationship for each glutamate receptor ( Figure 7G ).
Finally, we tested these predictions by performing slice patch clamp recordings from CA1 pyramidal neurons to detect PAR1-induced astrocytic glutamate release ( Figure 7J ). The released glutamate is detected as an NMDAR-mediated current in the presence of nominal external Mg 2+ (5 mM). We found that TFLLR induced a small but significant NMDAR-mediated current ( Figure 7K ), which was almost completely eliminated in the Best1 knockout mice ( Figure 7L ). TREK-1-shRNA injected into Best1 knockout mice further reduced the small portion of remaining NMDAR-mediated current ( Figure 7M ). To test whether astrocytic or neuronal Best1 is mediating the glutamate release, we employed the cell-type-specific gene-silencing system that combines the GFAP-CreERT2 mice (astrocytic Cre) or CaMKIICre mice (neuronal Cre) with Cre-lox-regulated shRNA cassette Ventura et al., 2004) . We could also achieve temporal control of Cre expression in GFAP-CreERT2 mice by intraperitoneal injection of tamoxifen. Using this system, we found that Best1-shRNA significantly reduced TFLLR-induced glutamate release in the absence of tamoxifen (sunflower oil injection) in GFAP-CreERT2 mice or in CaMKII-Cre mice (Figure 7N) , as compared to the scrambled shRNA control (Figure 7O ). On the other hand, tamoxifen injection significantly rescued the TFLLR-induced NMDAR current in GFAP-CreERT2 mice ( Figure 7O ), indicating that astrocytic Best1 is responsible for the majority of TFLLR-induced glutamate release. To see whether TFLLR-induced current is a genuine NMDAR-mediated current, we performed similar recordings in the presence of 2 mM external Mg 2+ and obtained instant I-V relationship upon voltage ramp ranging from À100mV to +20mV. The I-V relationship of TFLLR-induced current showed a typical V-shape that is a hallmark of Mg
2+
-dependent NMDAR-mediated conductance ( Figures 7P and 7R ). This V-shaped I-V was eliminated by the treatment with APV, a blocker of NMDAR (Figures 7Q and 7R) . Taken together, these results indicate that Best1-mediated astrocytic glutamate release targets neuronal postsynaptic NMDAR, whereas TREK-1-mediated release does not.
DISCUSSION
Our study answers the ongoing controversies about the astrocytic glutamate release mechanisms. Now we understand why many have reported the evidence for vesicular glutamate release from astrocytes. Many studies in the past used mechanical stimulation to induce glutamate release (Araque et al., 1998 (Araque et al., , 2000 Montana et al., 2004) . Our study demonstrates the existence of both BoToxB-sensitive and channel-mediated releases; strong stimuli, such as mechanical stimulation, cause BoToxBsensitive glutamate release, whereas GPCR activation leads to channel-mediated release. We also note the critical problems of using inhibitors of vesicular release such as Bafilomycin A1, Concanamycin A, and Tetanus toxin. These inhibitors actively remove the surface AMPA receptors, thus impairing the sensor for glutamate and obscuring the interpretation of the results. Furthermore, these inhibitors and BoToxB significantly reduced the surface expression of TREK-1 in heterologous expression system ( Figures S7C and S7D ) and Best1 channels in astrocytes ( Figures S7E and S7F) . Therefore, these inhibitors should be used with caution, and the past results should be reinterpreted.
Our electron microscopy results indicate that Best1 is preferentially located at the microdomains near synapses, whereas TREK-1 is preferentially located at the soma and processes, providing differential sources for fast glutamate release by TREK-1 away from the synapse and slow glutamate release by Best1 near the synapse. In the recent report by Agulhon et al. (2010) , the authors used MrgA1 transgenic mice with astrocytic expression of exogenous MrgA1 receptor and showed a lack of effect upon activation of this receptor. The authors concluded that astrocytic Ca 2+ had no effect on synaptic transmission and plasticity (Agulhon et al., 2010) . This lack of effect could be due to an inappropriate targeting of the exogenously introduced MrgA1 receptor (a G q -coupled GPCR), which should be targeted near Best1 channels in the distal microdomains for proper release and function. In contrast to the exogenous MrgA1, we demonstrate that the activation of endogenous PAR1 releases Ca 2+ -dependent astrocytic glutamate via Best1 channel and subsequently activates neuronal NMDAR. Furthermore, our study demonstrates that glutamate release upon receptor activation is mostly due to channel-mediated release ( Figure 6K ), which is in line with the recent review by Hamilton and Attwell (2010) and other previous reports suggesting anion-channel-mediated release but without identifying the molecular identity of the channel (Li et al., 2012; Takano et al., 2005) . We determined the molecular identity of the fast mode as TREK-1 and the slow mode as Best1 channel. We previously reported that tonic GABA release is mediated by Best1 in cerebellar astrocytes . We subsequently reported that astrocytes of CA1 hippocampus do not contain GABA, and thus there is very little tonic GABA release detected from CA1 pyramidal neurons (Yoon et al., 2011) . Although Best1 is permeable to both glutamate and GABA, it should mediate glutamate release from hippocampal astrocytes because they do not contain GABA. In addition, our study demonstrates that, when a G i -coupled GPCR (GABA B , CB1, or A1R) is activated, there is a concurrent induction of Ca 2+ -independent glutamate release that is linked to G i activation, dissociation of G bg , binding of G bg to N terminus of TREK-1, and opening of TREK-1 channel. Finally, we demonstrate the ability of a K2P channel permeating and releasing glutamate upon binding of G bg . There have been only few channels that directly interact with G bg . These include GIRK (Huang et al., 1995) and alpha subunits of some voltage-gated Ca 2+ channels . The K2P channel is a new member of the family of channels that show direct interaction with G bg . The remarkable ability of a potassium-permeable channel to dilate its pore to permeate large molecules such as glutamate is quite interesting. Pore dilation is a rare phenomenon that has been observed with few ion channels, such as TRPV1 (Binshtok et al., 2007) and P2X7 (Virginio et al., 1999) . A detailed structural analysis should give us new insights on how pore dilation in TREK-1 can occur upon the binding of G bg .
In conclusion, astrocytes display multiple routes of glutamate release, each with a unique molecular mechanism, specific timescale, differential location, and different neuronal target receptor. Such diversity teaches us that astrocytes, once a neglected brain cell type, are emerging as an important source of glutamate, which can potentially influence neuronal excitability under various physiological as well as pathological conditions.
EXPERIMENTAL PROCEDURES
Sniffer-Patch Technique Sniffer patch was composed of Fura-2 imaging for Ca 2+ from astrocytes and current recording from HEK293T cells expressing GluR1-L497Y. To release glutamate from astrocyte, PAR-1 was activated by pressure application of TFLLR peptide. On the day of experiment, cultured mouse astrocytes (HEK293T cells added) were incubated with 5 mM Fura-2 AM (mixed with 5 ml of 20% Pluronic acid) (Invitrogen) for 40 min, washed at room temperature, and subsequently transferred to the microscope stage for imaging. External solution contained (in mM): 150 NaCl, 10 HEPES, 3 KCl, 2 CaCl 2 , 2 MgCl 2 , and 5.5 glucose (pH adjusted to pH 7.3 and osmolarity adjusted to 325 mOsmol kg À1 ). Intensity images of 510 nm wavelength were taken at 340 nm and 380 nm excitation wavelengths by using iXon EMCCD (ANDOR). Two resulting images were used for ratio calculations in Imaging Workbench version 6.2 (Indec Systems). GluR1L497Y-mediated currents were recorded from HEK293T cells under voltage clamp (V h = -70mV) using Multiclamp 700B amplifier acquired with pClamp 9.2 (Molecular Devices). Recording electrodes (4-7MU) were filled with (mM): 110 Cs-Gluconate, 30 CsCl, 0.5 CaCl 2 , 10 HEPES, 4 Mg-ATP, 0.3 Na3-GTP, and 10 BAPTA (pH adjusted to 7.3 with CsOH and osmolarity adjusted to 290-310 mOsm/kg with sucrose). For simultaneous recording, Imaging Workbench was synchronized with pClamp 9.2. To study G i pathway, Pertussis toxin, pCDNA3.1-SS-ECFP-TM-Gi1-CG (GiCG), and pCDNA3.1-SS-ECFP-TM-Gs were used. To study the dissociation of G i -G bg pathway, pRK-b-Ark-C terminus, pIRES2-dsRED-Phosducin-C terminus, and specific G i agonists (Baclofen for GABA B , CCPA for adenosine receptor 1, and ACEA for Cannabinoid receptor) were used. To study G q pathway, BAPTA-AM and pSPORT6-RGS-2 were used. To inhibit vesicular release, Botulinum toxin was injected with impermeable Fura-2 to a single astrocyte. To inhibit anion channels, NPPB, NFA, DIDS, and quinine were used. To test whether glutamate release involved TREK-1, pSicoR-TREK-1-shRNA to gene-silence TREK-1 expression and pIRES2-GFP-TREK-1(rat) for the rescue experiment were used. To test whether glutamate release involves Best1, pSicoR-Best1-shRNA for blocking Best1 expression and pSicoRBest1-shRNA and pIRES2-dsRed-Best1 (shRNA-insensitive form) for rescue experiment were used.
Two-Cell Sniffer Patch
Upon membrane rupture, currents were recorded from astrocyte under voltage clamp (V h = -70mV). Recording electrodes (4-7MU) were filled with (mM): 5 glutamate, 135 CsCl, 0.5 CaCl 2 , 10 HEPES, 4 Mg-ATP, 0.3 Na3-GTP, 10 BAPTA, and 6.09 nM G bg (pH adjusted to 7.3 with CsOH and osmolarity adjusted to 290-310 mOsm/kg with sucrose). In the competitive peptide assay, 100 mM N1-4 synthesized peptides were added to patch pipette and injected into astrocyte. GluR1L497Y-mediated currents were recorded from HEK293T cells under voltage clamp (V h = -70mV). Recording electrodes (4-7 MU) were filled with (mM): 110 Cs-Gluconate, 30 CsCl, 0.5 CaCl 2 , 10 HEPES, 4 Mg-ATP, 0.3 Na3-GTP, and 10 BAPTA (pH adjusted to 7.3 with CsOH and osmolarity adjusted to 290-310 mOsm/kg with sucrose). Purified bovine G bg (Calbiochem 371768) was injected into astrocyte, and the current amplitude was measured 10 min after membrane rupture.
Biochemical Evidence for Interaction of TREK-1 and G g The binding partners of N terminus of TREK-1 were screened by yeast two-hybrid system (Y2H) (Kim et al., 2010) . The binding site of TREK-1 on GNG4 was identified by Y2H and was confirmed by MBP pull-down assay and coimmunoprecipitation. The binding domain of GNG4 on TREK-1 was (H) and TREK-1 (I) combined with immunostaining for GFP in hippocampal CA1 of GFAP-GFP mouse. Best1 and TREK-1 are stained with immunogold with silver enhancement (dark specks, arrowheads), and GFP is stained with immunoperoxidase (dark amorphous deposits, arrows). Pr, presynapse; Po, postsynapse. (J) Summary graph for percentage (%) of gold particles for TREK-1 and Best1 located on the plasma membrane of cell body, process, and microdomain (***1, p = 0.0005; **p = 0.008; ***2, p = 0.0001).
(K) Molecular model of receptor-mediated glutamate release in astrocyte. Upon PAR-1 activation, dissociated G bg activates TREK-1 to induce fast mode of glutamate release, whereas G aq -mediated signaling and Ca 2+ induce slow mode of Best1-mediated glutamate release.
All values are expressed as mean ±SEM. See also Figure S6 . According to the reconstructed release, the normalized responses are calculated. The release by TFLLR stimulation is divided into two modes of the leading transient (fast) followed by the smooth (slow).
(C) According to the simulation result, fast and slow modes release about 0.34 fmol and 1.35 fmol, respectively. Peak of fast mode is higher than that of slow mode, but slow mode continuously releases glutamate in comparison to fast mode where an instantaneous release occurs.
determined by coimmunoprecipitation after expressing N or C terminus of GNG4 in HEK293T cells, together with full-length TREK-1. 
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